http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0015401-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-08
filingDate 2000-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79faaa36863f46d3354f6064184246f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c1f74a97edf105e352f40668a6dc403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72002b8cb0bee0750a0cd99f4f52cda3
publicationDate 2002-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-0015401-A
titleOfInvention [(indol-3-yl) -cycloalkyl] -3-substituted azetidines for the treatment of central nervous system disorders
abstract Invention Patent: "[(INDOL-3-IL) -CYCLOLOQUIL] -3-SUBSTITUTED AZETIDINES FOR THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM". This invention relates to the new compounds, pharmaceutical compositions and processes of use of the compounds in the treatment of disorders of the central nervous system, such as anxiety and depression, the compounds having the formula (I), in which: X is NR, O , S (O) ~ m ~ is 0 to 2; n is 0 to 4; Ar is an aryl group of 6 to 12 carbon atoms, optionally substituted with 1 to 3 R ~ 3 ~ groups or a hetoroaryl group of 4 to 10 carbon atoms, optionally substituted with 1 to 3 R ~ 3 ~ groups; R and R ~ 2 ~ are independently H, straight chain alkyl of 1 to 6 carbon atoms, branched alkyl of 3 to 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, alkoxycarbonyl of 1 to 6 carbon atoms, alkylcarbonyl of 1 to 6 carbon atoms, aminocarbonyl or alkylaminocarbonyl of 1 to 4 carbon atoms; R ~ 1 ~ and R ~ 3 ~ are independently H, straight chain alkyl of 1 to 4 carbon atoms, branched alkyl of 3 to 6 carbon atoms, cycloalkyl of 3 to 8 carbon atoms, halo, alkoxy group of 1 to 4 carbon atoms, haloalkyl of 1 to 4 carbon atoms, OH, nitro, amino, sulfonyl, CN, carboxy, alkoxycarbonyl of 1 to 4 carbon atoms, alkylcarbonyl of 1 to 4 carbon atoms, aminocarbonyl or 1-alkylaminocarbonyl to 4 carbon atoms; and all crystalline forms or a pharmaceutically acceptable salt thereof.
priorityDate 1999-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411

Total number of triples: 22.